Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Kim Sablich


  • Evp & Gm, North America at Jazz Pharmaceuticals Plc (JAZZ), 2020-08-07
  • Chief Commercial Officer at Myovant Sciences Ltd. (MYOV), 2020-04-07
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MYOV $6.93 15 Officer 58,905 2020-03-18 Filing
MYOV $7.38 770 Officer 58,920 2020-03-18 Filing
MYOV $14.04 4,840 Officer 59,690 2020-01-15 Filing
MYOV $16.22 2,585 Officer 64,530 2019-12-18 Filing